120 completed, 77 unknown, 29 recruiting, 22 not yet recruiting. 102 Not applicable, 66 Phase 2, 29 Phase 3, 22 Phase 4, 21 Phase 1.
Follow Vitiligo: new trials by email Literature Review of Vitiligo trials Research Report on Vitiligo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vitiligo Registry for Adults and Children in the UK Dermatologic Disease, Vitiligo | Not yet recruiting | The Royal Wolverhampton Hospitals NHS Trust | 30 | 2026-12-15 | 2026-09-15 | |
| An Observational Study of Patients With Dermatologic Disease Vitiligo, Atopic Dermatitis | Not yet recruiting | Target PharmaSolutions, Inc. | 2000000 | 2026-09-01 | 2026-09-10 | |
| Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and Nb-UVB for Treating Vitiligo OXYGENE MEDICINAL LIQUIDE AIR PRODUCTS MEDICAL - Vitiligo Vulgaris | Phase 2 / Phase 3 | Not yet recruiting | Centre Hospitalier Universitaire de Nice | 5 | 2026-09-01 | 2026-06-05 |
| Fractional CO2 Laser vs Dermabrasion With 5-Fluorouracil for Acquired Leukoderma Fractional CO2 Laser, Dermabrasion, 5-Fluorouracil - Leukoderma, Hypopigmentation | Not applicable | Not yet recruiting | Al-Azhar University | 16 | 2026-08-26 | 2026-09-24 |
| PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents Vitiligo | Recruiting | CorEvitas | 2500 | 2026-08-21 | 2026-08-26 | |
| A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo MH004 1.0% Ointment, MH004 Placebo Ointment - Vitiligo | Phase 3 | Recruiting | Minghui Pharmaceutical (Hangzhou) Ltd | 405 | 2026-08-04 | 2026-08-11 |
| Influence of Adjunctive Acids Use on Esthetic Outcomes of Gingival Melanin Depigmentation: A Periodontal-Operative Pilot Randomized Clinical Trial Citric acid - Gingival Pigmentation | Not applicable | Not yet recruiting | Dijlah University | 30 | 2026-08-01 | 2026-07-16 |
| Assessment of Vitiligo Lesions Using Polarized Dermoscopy, Sub-Ultraviolet Reflectance Dermoscopy, and Ultraviolet Dermoscopy Vitiligo | Recruiting | Istanbul Training and Research Hospital | 100 | 2026-07-01 | 2026-09-29 | |
| NCMT Technique and Jodhpur Technique and Excimer Laser in Treatment of Non Vitiligo Leucoderma Melanocyte Keratinocyte Transplantation Procedure (MKTP), Jodhpur Technique, 308-nm Excimer Laser - Leukoderma | Not applicable | Not yet recruiting | Al-Azhar University | 22 | 2026-07-01 | 2026-06-23 |
| Study of D-2570 in Subjects With Non-Segmental Vitiligo D-2570 Dose 1, D-2570 Dose 2, Placebo - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | Recruiting | InventisBio Co., Ltd | 160 | 2026-06-11 | 2026-07-15 |
| Efficacy and Safety of Ruxolitinib Cream in Chinese Children Aged 2-11 Years With Non-segmental Vitiligo Ruxolitinib 1.5% Cream BID - Vitiligo | Phase 3 | Not yet recruiting | The Children's Hospital of Zhejiang University School of Medicine | 20 | 2026-06-01 | 2026-05-19 |
| Comparison of Efficacy and Safety Psoralen Combined With Ultraviolet A (PUVA) Vs Tofacitinib in the Treatment of Generalized Vitiligo. Group A recieving PUVA therapy, Group B receiving Tablet Tofacitinib - Vitiligo, Generalized | Early Phase 1 | Not yet recruiting | Hayat Abad Medical Complex, Peshawar | 64 | 2026-06-01 | 2026-01-30 |
| A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo GR2301 injection, Placebo - Vitiligo | Phase 1 / Phase 2 | Not yet recruiting | Genrix (Shanghai) Biopharmaceutical Co., Ltd. | 116 | 2026-06-01 | 2026-06-15 |
| Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study. Crisaborole 2% topical ointment, tacrolimus 0.1%, Excimer Light therapy - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 3 | Recruiting | Cairo University | 35 | 2026-05-15 | 2026-10-29 |
| Topical Methotrexate with Fractional CO2 Laser in Treatment of Non Segmental Vitiligo Fractional CO2 laser assisted PDT - Vitiligo | Not applicable | Not yet recruiting | Assiut University | 50 | 2026-05-01 | 2025-03-14 |
| A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo LY4005130, Placebo - Vitiligo, Non-Segmental Vitiligo (NSV) | Phase 2 | Recruiting | Eli Lilly and Company | 66 | 2026-04-14 | 2026-10-08 |
| Topical Delgocitinib for Facial Vitiligo Delgocitinib cream - Vitiligo | Phase 2 | Active not recruiting | Lone Skov | 12 | 2026-04-08 | 2026-09-15 |
| Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Intravenous Infusion, Oral Prednisone, Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (hUC-MSC-Exos) Local Injection - Vitiligo, Mesenchymal Stem Cells | Phase 1 / Phase 2 | Not yet recruiting | Xijing Hospital | 96 | 2026-04-01 | 2026-04-09 |
| Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study NB-UVB combined with microneedling and topical 10% secretome, receives NB-UVB combined with intradermal secretome injection, NB-UVB alone - Vitiligo | Phase 2 / Phase 3 | Not yet recruiting | Yohanes Firmansyah, dr, MH, MM | 150 | 2026-03-18 | 2026-04-03 |
| The Value of Adding Mini-oral Pulse Steroid Therapy in Preventing Peri-lesional Halo Post Non-cultured Epidermal Cell Suspension (NCES) in Cases With Stable Segmental and Non-acral Vitiligo. Non-cultured epidermal cell suspension (NCES) surgery, Oral mini pulse, Excimer Sessions - Vitiligo | Phase 4 | Not yet recruiting | Cairo University | 60 | 2026-03-15 | 2026-03-16 |
Showing 20 of 293. Sign in to see all of them.
Psoriasis (20) · Dermatitis, Atopic (18) · Alopecia Areata (16) · Autoimmune Diseases (9) · Hidradenitis Suppurativa (9) · Skin Diseases (8) · Pigmentation Disorders (7) · Hypopigmentation (6) · Eczema (5) · Graves Disease (5) · Hyperpigmentation (5) · Multiple Sclerosis (5) · Acne Vulgaris (4) · Arthritis, Rheumatoid (4)
Skin and Connective Tissue Diseases (292) · Hypopigmentation (287) · Pigmentation Disorders (286) · Skin Diseases (285) · Pathological Conditions, Signs and Symptoms (26) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (25) · Immune System Diseases (25) · Genetic Diseases, Inborn (22) · Skin Diseases, Genetic (22) · Skin Diseases, Papulosquamous (21) · Skin Diseases, Eczematous (20) · Dermatitis (19) · Pathologic Processes (19) · Hypersensitivity, Immediate (18) · Hypotrichosis (18)
Phototherapy (13) · Percutaneous Collagen Induction (11) · Tacrolimus (11) · Lasers, Excimer (8) · ruxolitinib (8) · Fluorouracil (6) · Ointments (6) · Blood Specimen Collection (5) · Dermabrasion (5) · afamelanotide (5) · Therapeutics (4) · Bimatoprost (3) · Dexamethasone (3) · Lasers, Gas (3) · Triamcinolone Acetonide (3)
Cairo University (21) · Assiut University (16) · Centre Hospitalier Universitaire de Nice (16) · Sohag University (10) · Henry Ford Health System (7) · Incyte Corporation (7) · University Hospital, Bordeaux (7) · Xijing Hospital (6) · Al-Azhar University (5) · The Catholic University of Korea (5) · University of British Columbia (5) · Kasr El Aini Hospital (4) · Momentum Data (4) · South Valley University (4) · Avita Medical (3)
United States (66) · Egypt (41) · France (38) · China (25) · Canada (19) · Italy (10) · South Korea (10) · Germany (9) · Netherlands (9) · Pakistan (9) · Spain (9) · United Kingdom (9) · Belgium (6) · Poland (6) · Australia (5)
Passeron Thierry, PhD (6) · Andrew McGovern, MD (4) · Harvey Lui, MD, FRCPC (4) · Kathleen Butler, MD (4) · Iltefat H Hamzavi, MD (3) · Chunying Li (2) · Laura Dalfonso (2) · Nanette Silverberg, MD (2) · Ramadan Saleh, MD (2) · Samia Esmat, MD (2) · Adrian B Cuellar-Barboza, MD (1) · Ahmad Aleisa, MD (1)
PMID 41125994, PMID 20364383, PMID 23919018, PMID 25596811, PMID 30601885, PMID 36260792, PMID 40156697, PMID 12410698, PMID 12516826, PMID 15149497, PMID 15888156, PMID 17659004, PMID 19067714, PMID 19481375, PMID 19627411, PMID 19787413, PMID 20197747, PMID 20413357, PMID 20961233, PMID 21275943, PMID 21406109, PMID 21451378, PMID 22676819, PMID 23003920, PMID 23560296, PMID 23783059, PMID 24304125, PMID 24507484, PMID 25006795, PMID 25213385, PMID 25230094, PMID 25269389, PMID 25545321, PMID 25902042, PMID 26695436, PMID 27102484, PMID 27329330, PMID 27627998, PMID 28157763, PMID 28355423, PMID 29387874, PMID 29617528, PMID 29900173, PMID 30131803, PMID 30423329, PMID 30552832, PMID 30681166, PMID 31209143, PMID 31643084, PMID 31753192
2023 (4), 2025 (4), 2019 (2), 2009 (1), 2018 (1), R33AR077495 (1)